XBiotech Inc (XBIT)
6.83
+0.21
(+3.17%)
USD |
NASDAQ |
Nov 22, 16:00
6.88
+0.05
(+0.73%)
After-Hours: 20:00
XBiotech Enterprise Value: 35.08M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 35.08M |
| November 21, 2024 | 28.68M |
| November 20, 2024 | 24.72M |
| November 19, 2024 | 30.21M |
| November 18, 2024 | 30.21M |
| November 15, 2024 | 29.90M |
| November 14, 2024 | 39.35M |
| November 13, 2024 | 43.31M |
| November 12, 2024 | 42.98M |
| November 11, 2024 | 49.38M |
| November 08, 2024 | 57.00M |
| November 07, 2024 | 51.21M |
| November 06, 2024 | 78.34M |
| November 05, 2024 | 54.26M |
| November 04, 2024 | 49.38M |
| November 01, 2024 | 50.91M |
| October 31, 2024 | 48.16M |
| October 30, 2024 | 52.12M |
| October 29, 2024 | 44.96M |
| October 28, 2024 | 61.88M |
| October 25, 2024 | 45.42M |
| October 24, 2024 | 47.55M |
| October 23, 2024 | 44.50M |
| October 22, 2024 | 55.78M |
| October 21, 2024 | 57.61M |
| Date | Value |
|---|---|
| October 18, 2024 | 57.00M |
| October 17, 2024 | 56.70M |
| October 16, 2024 | 61.88M |
| October 15, 2024 | 53.95M |
| October 14, 2024 | 61.57M |
| October 11, 2024 | 53.95M |
| October 10, 2024 | 39.32M |
| October 09, 2024 | 42.68M |
| October 08, 2024 | 36.58M |
| October 07, 2024 | 46.03M |
| October 04, 2024 | 54.87M |
| October 03, 2024 | 41.76M |
| October 02, 2024 | 55.48M |
| October 01, 2024 | 52.43M |
| September 30, 2024 | 62.49M |
| September 27, 2024 | 41.11M |
| September 26, 2024 | 25.57M |
| September 25, 2024 | 21.00M |
| September 24, 2024 | 26.79M |
| September 23, 2024 | 28.32M |
| September 20, 2024 | 28.32M |
| September 19, 2024 | 63.65M |
| September 18, 2024 | 49.94M |
| September 17, 2024 | 46.59M |
| September 16, 2024 | 37.15M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-458.09M
Minimum
Mar 16 2020
779.34M
Maximum
Dec 24 2019
69.69M
Average
42.45M
Median
Mar 24 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.314M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.015M |
| Total Expenses (Quarterly) | 7.904M |
| EPS Diluted (Quarterly) | -0.16 |
| Earnings Yield | -15.81% |
| Normalized Earnings Yield | -14.75 |